ORAMED PHARMACEUTICALS INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ORAMED PHARMACEUTICALS INC. has filed 941 SEC EDGAR filings since 29 Nov 2002

SEC filing history

Showing 351-375 of 782 matching filings.

Per page
25
Current page
15
4

OWNERSHIP DOCUMENT

Filing date
15 Jul 2019
Reporting date
11 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
10 Jul 2019
Reporting date
31 May 2019
Next action
Verify source filing
8-K File 001-35813

FORM 8-K

Filing date
01 Jul 2019
Reporting date
25 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Jun 2019
Reporting date
01 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
16 May 2019
Reporting date
13 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Apr 2019
Reporting date
15 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
16 Apr 2019
Reporting date
12 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Apr 2019
Reporting date
10 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
10 Apr 2019
Reporting date
28 Feb 2019
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
28 Mar 2019
Reporting date
25 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
13 Mar 2019
Reporting date
11 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2019
Reporting date
26 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2019
Reporting date
26 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2019
Reporting date
26 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Feb 2019
Reporting date
26 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-79895

AMENDED FORM SC 13G

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
14 Jan 2019
Reporting date
30 Nov 2018
Next action
Verify source filing
SC 13G/A File 005-79895

SABBY 13G-A ORMP 1.07.19

Filing date
07 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
14 Dec 2018
Reporting date
11 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-35813

ANNUAL REPORT

Filing date
28 Nov 2018
Reporting date
31 Aug 2018
Next action
Verify source filing
3

3 filing

Filing date
20 Nov 2018
Reporting date
15 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
08 Nov 2018
Reporting date
04 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
17 Sep 2018
Reporting date
17 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
30 Aug 2018
Reporting date
28 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .